Everyone, all over the world, deserves to live a long life in full health. In order to achieve this goal, we need a comprehensive picture of what disables and kills people across countries, time, age, and sex. The Global Burden of Disease (GBD) study quantifies health loss from hundreds of diseases, injuries, and risk factors. While global- and national-level estimates have been essential to understanding overarching trends in child mortality, infectious diseases, access to clean water, and other health-related topics, they can mask local variations within national borders. Combining local detail with broad coverage – producing 5-by-5-kilometer estimates for entire continents and, eventually, the world – would give health officials everywhere the tools to make locally informed decisions. This presentation will highlight key results from the GBD study as well as new research bringing this analysis to the local level. After viewing this lecture, participants should be able to: 1. Recognize the importance of pathology and laboratory medicine in global health systems 2. Name at least three barriers to delivering pathology and laboratory capacity in low- and middle-income countries 3. Identify strategies for improving pathology and laboratory capacity in low- and middle-income countries Emily Glynn, MD, MPH Associate Professor, Hematopathology Department of Laboratory Medicine & Pathology University of Washington President, Pathologists Overseas 10/08/25 The University of Washington is committed to ensuring digital accessibility in our services, programs, and activities. If you encounter accessibility barriers using videos found on this channel, please contact UW Video at uwvideo [at] uw [dot] edu.